Clinical Trials Directory

Trials / Completed

CompletedNCT04700007

Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)

Effect of Intradermal Morphine Application on Histaminergic and Non-histaminergic Itch and Related TRPV1 and Antihistamine Treatments (2nd Sub-project)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The aim of our 2nd sub-project is to clarify if the capsaicin receptor TRPV1 is implicated in the mechanism of morphine-induced mast cell degranulation. Moreover, we also aim to clarify if the mechanism of opioid-induced itch relay on the histaminergic pathway by using the antihistamine (diphenhydramine) to suppress the release of histamine from peripheral mast cells.

Conditions

Interventions

TypeNameDescription
DRUGCapsaicinA capsaicin patch will be applied on a 3x3 cm squared area on the volar forearm. The patch will be left in place for 24h after which it will be removed.
DRUGDiphenhydramineDiphenhydramin cream 1% (Restamine®) will be applied on a 3x3 cm squared predetermined area on the volar forearm for 24 hours.
DRUGMorphine ChlorideMorphine solution (0.1mg/ml, Morphine Hydrochloride) 50 μl will be applied intradermally to the center of a predetermined area on the volar forearm by a 1 ml syringe.
DRUGIsotonic salineinjections of isotonic saline (0.05 ml, 0.9%) as vehicle will be performed.
DRUGHistamineA small drop of histamine dihydrochloride (1%, in saline) will be applied to a previously determined area on the volar forearm followed by a prick through the drop.

Timeline

Start date
2021-01-18
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-01-07
Last updated
2022-01-27

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04700007. Inclusion in this directory is not an endorsement.